Meeting
2016 ASCO Annual Meeting
Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).
Authors
Philipp Harter
Kliniken Essen Mitte, Essen, Germany
Philipp Harter , Jan Hauke , Florian Heitz , Alexander Reuss , Stefan Kommoss , Frederik Marme , Andre Heimbach , Katharina Prieske , Lisa Katharina Richters , Alexander Burges , Guido Neidhardt , Nikolaus de Gregorio , Ahmed El-Balat , Felix Hilpert , Werner Meier , Martin Leonhard Heubner , Karin Kast , Ioana Braicu , Eric Hahnen , Rita K. Schmutzler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Clinical Trial Registration Number
NCT02222883
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5538)
DOI
10.1200/JCO.2016.34.15_suppl.5538
Abstract #
5538
Poster Bd #
361
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Beyond BRCA1 and BRCA2: Implementation of a multigene panel for the upfront testing of germline mutations in ovarian cancer.
First Author: Maria Beatriz Mira
Poster
2018 ASCO Annual Meeting
Impact of pre-surgical germline multigene panel testing on choice of surgery for breast cancer.
First Author: Elena Zarcaro
Poster
2017 ASCO Annual Meeting
BRCA-like classification in ovarian cancer: Results from the AGO-TR1-trial.
First Author: Lisa Katharina Richters
Poster
2016 ASCO Annual Meeting
Prevalence of somatic mutations in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1 study).
First Author: Eric Hahnen